The 6-week intervention demonstrated significantly greater efficacy compared to longer durations (6 weeks), which showed diminished effects
That's exactly why peptide therapy shouldn't be a guessing game or a DIY experiment with vials from the internet
Retatrutides ~24.2% (48 wk, 12 mg monotherapy) and cagrilintides ~10.8% (26 wk, 4.5 mg monotherapy) differ in duration and dose, and cagrilintides strongest data are combination (CagriSema) data
5-Amino-1MQ functions as a metabolic regulator rather than a stimulant, influencing foundational pathways that determine how the body stores and utilizes energy
Clayton AH, Lucas J, Kroll R, et al
These data further confirm our Compass predictions (Fig